Funding for translational research in burden of disease and genomics
A total of $2.39 million has been awarded to four Western Australian researchers to support translational research in the areas of burden of disease and genomics.
The Future Health Research and Innovation (FHRI) Fund’s Translation Fellowships – Burden of Disease and Genomics provides fellowship funding for up to 3 years.
Researchers are supported to undertake research in collaboration with a WA-based translation partner who will support early translation of the research in the areas of disease causing the greatest burden to WA including cancer, mental health, substance use disorders, musculoskeletal conditions, cardiovascular diseases and injuries and/or in the area of genomics.
Applications were competitively assessed based on merit by an independent assessment panel and recipients will receive a share of $2.39 million.
The Translation Fellowships – Burden of Disease and Genomics recipients are shown below.
| Recipient | Responsible entity | Project title | Funding awarded |
| Dr Emma Carlin | University of Western Australia | Establishing the foundations for clinical coding of social and emotional wellbeing within Aboriginal Community Controlled Health Services | $600,000 |
| Dr Jonathan Chee | University of Western Australia | Repurposing anti-copper drugs to improve mesothelioma therapy | $599,157 |
| Dr Aleksandra Miljevic | Perron Institute for Neurological and Translational Science | Advancing non-invasive brain stimulation with genetic screening as a treatment modality for youth with depression and suicide ideation | $599,132 |
| Dr Hadi Afsharan | University of Western Australia | Hassle-free heart disease screening is possible? A non-invasive retinal imaging technology to screen for cardiovascular diseases | $594,339 |